BEIJING, CHINA, November 20, 2009 - MicroConstants China Co., Ltd., a Contract Research Organization (CRO) specializing in bioanalysis and pharmacokinetics, announces their participation in the National Institute of Health’s (NIH) Principles of Clinical Pharmacology training program in Beijing, China. Dr. David Yang, president of MicroConstants China, was a panelist at the event, and several MicroConstants employees assisted NIH experts by providing translation services during the training program.
On November 16 - 20, 2009 NIH and GlobalMD, together with the Chinese Association of Clinical Pharmacology, organized the Principles of Clinical Pharmacology training program in Beijing. The program was designed to educate clinical pharmacologists in China on recent advancements in the field, and the FDA review process of clinical pharmacology studies for new drug development.
On the final day of the training program, Dr. David Yang participated on a panel covering a variety of topics such as regulatory policies, clinical pharmacology and drug development strategy for Chinese biotech companies. Other panelists included Dr. Yi Feng, director of office of evaluation management and communications at the Center for Drug Evaluation, China State FDA; Dr. Liu Ze-Yuan, director of clinical pharmacology at the 307 Hospital of People’s Liberation Army; and Dr. Mao Yi-Min, director of clinical pharmacology at Renji Hospital in Shanghai.
MicroConstants China also participated in the event by assisting with the translation of presentation materials, and serving as translators during the training program for advanced topics such as population pharmacokinetics and pharmacometrics. Four of MicroConstants’ employees provided translation services during the event ensuring that trainees were able to gain full understanding of all program topics.
Approximately 100 clinical pharmacologists including clinical researchers from government hospitals, faculty members from medical universities, and clinical research professionals from domestic and international pharmaceutical companies in China attended the four-day training program.
About MicroConstants, Inc. and MicroConstants China Co., Ltd.
MicroConstants is a privately held Contract Research Organization (CRO) that provides high quality bioanalytical, drug metabolism, pharmacokinetic and immunology services to pharmaceutical and biotech companies worldwide. MicroConstants specializes in HPLC/MS/MS, and provides expertise in method development, validation and routine analytical testing. MicroConstants was founded in 1998, and is headquartered in San Diego, CA. In 2007, MicroConstants established its second facility in Beijing, China to bring US GLP-compliant bioanalytical services to clients conducting pre-clinical and clinical PK studies in China. For more information about MicroConstants, please visit our website at: http://www.microconstants.com/
On November 16 - 20, 2009 NIH and GlobalMD, together with the Chinese Association of Clinical Pharmacology, organized the Principles of Clinical Pharmacology training program in Beijing. The program was designed to educate clinical pharmacologists in China on recent advancements in the field, and the FDA review process of clinical pharmacology studies for new drug development.
On the final day of the training program, Dr. David Yang participated on a panel covering a variety of topics such as regulatory policies, clinical pharmacology and drug development strategy for Chinese biotech companies. Other panelists included Dr. Yi Feng, director of office of evaluation management and communications at the Center for Drug Evaluation, China State FDA; Dr. Liu Ze-Yuan, director of clinical pharmacology at the 307 Hospital of People’s Liberation Army; and Dr. Mao Yi-Min, director of clinical pharmacology at Renji Hospital in Shanghai.
MicroConstants China also participated in the event by assisting with the translation of presentation materials, and serving as translators during the training program for advanced topics such as population pharmacokinetics and pharmacometrics. Four of MicroConstants’ employees provided translation services during the event ensuring that trainees were able to gain full understanding of all program topics.
Approximately 100 clinical pharmacologists including clinical researchers from government hospitals, faculty members from medical universities, and clinical research professionals from domestic and international pharmaceutical companies in China attended the four-day training program.
About MicroConstants, Inc. and MicroConstants China Co., Ltd.
MicroConstants is a privately held Contract Research Organization (CRO) that provides high quality bioanalytical, drug metabolism, pharmacokinetic and immunology services to pharmaceutical and biotech companies worldwide. MicroConstants specializes in HPLC/MS/MS, and provides expertise in method development, validation and routine analytical testing. MicroConstants was founded in 1998, and is headquartered in San Diego, CA. In 2007, MicroConstants established its second facility in Beijing, China to bring US GLP-compliant bioanalytical services to clients conducting pre-clinical and clinical PK studies in China. For more information about MicroConstants, please visit our website at: http://www.microconstants.com/
